Connor, Clark & Lunn Investment Management (CC&L)’s Meridian Bioscience Inc VIVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-15,571
| Closed | -$363K | – | 1175 |
|
|
2020
Q2 | $363K | Sell |
15,571
-87,329
| -85% | -$2.04M | ﹤0.01% | 812 |
|
|
2020
Q1 | $864K | Buy |
102,900
+36,200
| +54% | +$304K | 0.01% | 589 |
|
|
2019
Q4 | $652K | Sell |
66,700
-38,575
| -37% | -$377K | ﹤0.01% | 617 |
|
|
2019
Q3 | $999K | Buy |
105,275
+22,750
| +28% | +$216K | 0.01% | 546 |
|
|
2019
Q2 | $980K | Buy |
+82,525
| New | +$980K | 0.01% | 573 |
|
|
2019
Q1 | – | Sell |
-22,850
| Closed | -$397K | – | 1072 |
|
|
2018
Q4 | $397K | Sell |
22,850
-72,900
| -76% | -$1.27M | ﹤0.01% | 748 |
|
|
2018
Q3 | $1.43M | Buy |
95,750
+27,425
| +40% | +$409K | 0.01% | 503 |
|
|
2018
Q2 | $1.09M | Buy |
68,325
+23,425
| +52% | +$372K | 0.01% | 596 |
|
|
2018
Q1 | $638K | Buy |
44,900
+18,300
| +69% | +$260K | ﹤0.01% | 537 |
|
|
2017
Q4 | $372K | Buy |
26,600
+10,225
| +62% | +$143K | ﹤0.01% | 659 |
|
|
2017
Q3 | $234K | Buy |
+16,375
| New | +$234K | ﹤0.01% | 735 |
|